Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thank you Meddymo :-)
wet myself, need a nappy change lol
Fully agree QuickDraw. Great post.
I have to say in terms of toilet roll......Vlad seems like a bidet kinda guy to me. IMO but DYOR.
May i but in, in respect of COVID I think market is after "a" Hemo progress update. Hemo are a while off commercialising a COVID product (excluding mice which likely have NDA's). They aren't out of pre-clinical stage for their antibody treatment work. Any partner COVID updates e.g. Orgenesis vaccine and hopefully others is atvthe will of partners.
We are also waiting on results of feasibility study of cytokine storm indicators test. Basing on recent experience i estimate commercial test would be 3>5 months away if at all.
News that a treatment or vaccine is progressing to phase 1 will have a material impact on SP imo.
I've no expectations of a test, suspect feasibility update will move price and then we would follow a similar share price to development cycle followed by the test companies, granted with it being a tinny peice of the portfolio. Test is way down on my priority list, along with what toilet roll Vlad uses lol
#CDX #Leukaemia #HemoHeroMice
Share price is where it is right now for the simple fact that the projects currently being progressed are not at the stage of commercial realisation. i.e. they do not yet bring in revenue. As soon as each project passes reached the point of forecasted commercials then we will take off. That is why all believers and LTH's are not trading this share because results are expected anytime in the near future. When that happens, it should be a case of 'Fire up the Quattro!' and hold onto your hats.
Patience will be rewarded.
GLA
I agree Applegarth but we really must maintain perspective, the Sp is at 7p for a reason.
Let’s see on the next RNS how much progress they are making, could do with a positive Covid update as that would sort out the price.......
If Hemo come up with anything positive on any drug/compound at ANY stage of development...we will be offered a contract farn in deal immediately. So, yes to be rubbing shoulders with big pharma is a big motivator for me. Any hint from any source the sp will be history.
The last update on Covid was a few months back and if they are able to create a new test that checks for post issues, then it will make a huge difference to those whom have contracted Covid.
In the current circumstances, the world needs news and HEMO are not providing much of an update like others are on a regular basis. But still happy with my investment here.
I would have expected some RNS early this week to waken the Investors but still only Monday.
Nextlink - I am relaxed as I've taken my initial investment cash out through profits and sit with a decent holding taking a risk on a portlfolio, all paid for by someone else's money.
Fair comment, we know next to nothing about our work / progress on COVID. I agree it's a tense time. Plenty to expect, just need to start hearing about it :) but I'm relaxed about my investment here
Diggitt best sell if you hold.
You can relax and leave us with all this risk.
Good Luck
For sure, except I am also completely skeptical about anything on COVID. But yes, there is a portfolio, so not a one-trick pony and a number of rolls of the dice/mice.
On COVID that's similar to my view on EL...other than us blowing our own trumpet and people dreaming of links to other pharma's or where our solution might fit in, I've seen nothing substantiated that says we have anything real under development or at any decent stage of development. Ideas sure but not much more than that. More than happy to be corrected on that though.
Agreed. Could all go **** up. But then we have COVID, Hu-Phec, going alone and licensing ourselves etc etc etc. This is why I like HEMO. Working with big players on multiple fronts. It's not a coin flip like most of the other pharmas in the microcap space right now. Imo.
Except it happens. We are not in control of everything and bad luck happens / decisions go against you. I assume Hemo is 1 of [100] R&D programs EL are involved in which all count themselves as revolutionary.
Have EL ever talked us up? If I had heard them saying stuff, and not us presuming stuff and talking ourselves up, then I'd allow myself to start feeling warmer and fuzzier.
mjng - you're absolutely right, this certainly an option. What I would say however, is why spend a full 2 year term working together with a microcap if you weren't very interested in what it can deliver? Why let Hemo announce who you are in July after this 2 year period where you've suppressed this info? Why announce that you want to be aggressively buying out small companies throughout the year of 2020 and bin a clearly revolutionary bit of biology that you've pumped significant time, resource and money into?
Up to you to feel how you want about this, don't let me influence you, but I would say it's staring us in the face :)
In terms of the share price getting up to 70p - 80p then Lilly have to take up the option, people seem to think that is a definite, am I missing something but what happens if they say they do not want to exercise the option??
gla
Bekind, that is correct our scientists should be focusing on what they do best, but a CEO or MD of a business, which Hemo is by the way, should be ensuring that PR happens both B2B and consumer, I don't understand why people have difficulty in grasping that??
GLA
Anything short of 70-80p by Christmas would be a bit of a disappointment imo, but I agree with your sentiments Bekind - relax, people! COVID and Eli Deal / CDX progress should get us there comfortably. Nevermind all the the other work that's going on.... Feel free to challenge this, though I imagine this would be a moderate view if you look at some of the meteoric SP rises that occur on positive COVID news / finance details for licensing drugs with what I will call "super major" pharmaceutical companies. This is why Vlad isn't interested in what micro-shareholders are whispering. When this company delivers, and it will, I think us small-timers will be blown away by where this company is heading. As always, imo, dyor. Plenty of nice RNS's to flick through for those who are unsure...
Hemogenyx cytokine test could be a game changer in allowing a more detailed report for providing therapeutics specific to which category you fall into. Its evident that those who have battled COVID and recovered, have other ailments. Will this be the next news to drop in respect of the fight against COVID?
I'm not sure why people r focusing on PR. This isn't media or IT company.
Science needs perfection and these guys are rightly focusing on that. Given the product line ... A flurry of news expected. Sit back and relax. It's a multi-bagger! I expect this to be in at lest 50's by mid next year.
Our PR isnt the best but as others have said, the work will speak volumes when it lands. Rather have a decent product to market, than excellent PR. Stronger SP with product v's Smoke & Mirrors.
It did indeed come up on a lot of Social Media at the weekend that I follow and nice rise for those invested.
Morning All,
A quiet Monday AM for those invested and SP doing its usual small movement. Not a lot going on this morning for HEMO but that doesn't mean news isn't just around the corner. Vlad was quiet on Twitter at the weekend, too busy with the pipeline.